EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of lysyl oxidase expression with clinicopathological features in colorectal adenocarcinomas

Ayça Dilşad Çağlayan, Seda Kahraman, Doğukan Çanakçı, Mustafa Tahtacı, Ayşegül Aksoy Altınboğa, Hayriye Tatlı Doğan

International Journal of Colorectal Disease · 24.03.2025 · 40 (1)

DOI: 10.1007/s00384-025-04852-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 24.03.2025. Verfasst von Ayça Dilşad Çağlayan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pathology, Ege University, İzmir, Turkey. Hauptthemen laut MEDLINE: Protein-Lysine 6-Oxidase, Colorectal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Colorectal adenocarcinoma (CRC) is one of the leading causes of cancer-related mortality worldwide. Within the tumor microenvironment, neoplastic cells, along with tumor-promoting fibroblasts, contribute to the progression of CRC. Lysyl oxidase (LOX), an enzyme involved in this process facilitates collagen cross-linking within the extracellular matrix and plays a crucial role in remodeling the tumor microenvironment (TME) and promoting metastasis through epithelial-mesenchymal transition (EMT). This study investigates LOX expression in both tumor cells and the tumor stroma in relation with clinicopathological features in CRC patients. METHOD: Immunohistochemical staining of LOX proteins was performed on tissue microarrays from colorectal tumor samples taken from resection specimens. LOX expression was quantified in tumor cells and stroma. The correlation between the expression of LOX and clinicopathological parameters was analyzed. RESULTS: A positive correlation was observed between peritumoral stromal LOX expression and LOX expression in the tumor epithelium. High expression of LOX in tumor cells was significantly associated with poorer progression-free survival (PFS) among patients. Low tumor budding was observed in tumors with low stromal LOX expression. CONCLUSION: The current study indicates that LOX may be an important contributor to CRC progression. The findings of this series, in which LOX expression correlated with tumor budding and survival, support a contribution for LOX to EMT and metastasis. Furthermore, LOX expression in both the tumor cell and stromal compartment may add information to improve prognosis in CRC management. These findings, however, have to be validated in further studies, as does also the investigation of LOX as a potential therapeutic target in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Lysine 6-OxidaseColorectal NeoplasmsAdenocarcinomaHumansMaleFemaleMiddle AgedAgedEpithelial-Mesenchymal TransitionTumor MicroenvironmentStromal CellsProgression-Free Survival

Stichwörter der Autor:innen

Colorectal adenocarcinomaEpithelial-mesenchymal transitionLysyl oxidasePrognosisTumor stroma

Substanzen

Protein-Lysine 6-OxidaseLOX protein, human

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Pathology, Ege University, İzmir, Turkey.
  • Department of Medical Oncology, Ankara Yıldırım Beyazıt University, Ankara, Turkey.
  • Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey.
  • Department of Gastroenterology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey.
  • Department of Pathology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey.
  • Department of Pathology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey. hayriyetatli@gmail.com.

Zitieren

APA

Çağlayan, A. D., Kahraman, S., Çanakçı, D., Tahtacı, M., Altınboğa, A. A., & Doğan, H. T. (2025). Association of lysyl oxidase expression with clinicopathological features in colorectal adenocarcinomas. International Journal of Colorectal Disease, 40(1). https://doi.org/10.1007/s00384-025-04852-7

Vancouver

Çağlayan AD, Kahraman S, Çanakçı D, Tahtacı M, Altınboğa AA, Doğan HT. Association of lysyl oxidase expression with clinicopathological features in colorectal adenocarcinomas. International Journal of Colorectal Disease. 2025;40(1). doi:10.1007/s00384-025-04852-7

BibTeX
@article{alayan2025,
  author = {Çağlayan, Ayça Dilşad and Kahraman, Seda and Çanakçı, Doğukan and Tahtacı, Mustafa and Altınboğa, Ayşegül Aksoy and Doğan, Hayriye Tatlı},
  title = {Association of lysyl oxidase expression with clinicopathological features in colorectal adenocarcinomas},
  journal = {International Journal of Colorectal Disease},
  year = {2025},
  volume = {40},
  number = {1},
  doi = {10.1007/s00384-025-04852-7}
}
Kostenlos starten →